1. ADVANCE-1: An adapted collaborative benchmarking approach in centre-based lung cancer care. (January 2021) Authors: McCann, Brendan; Muhr, Riccardo; O'Rourke, Noelle; Milroy, Robert; Kollmeier, Jens; Misch, Daniel; van der Horst, Joris; Morrison, David; Bauer, Torsten; Massalski, Oliver; Blum, Torsten Gerriet Journal: Lung cancer Issue: Volume 151(2021) Page Start: 44 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Machine learning reveals a PD-L1–independent prediction of response to immunotherapy of non-small cell lung cancer by gene expression context. (November 2020) Authors: Wiesweg, Marcel; Mairinger, Fabian; Reis, Henning; Goetz, Moritz; Kollmeier, Jens; Misch, Daniel; Stephan-Falkenau, Susann; Mairinger, Thomas; Walter, Robert F.H.; Hager, Thomas; Metzenmacher, Martin; Eberhardt, Wilfried E.E.; Zaun, Gregor; Köster, Johannes; Stuschke, Martin; Aigner, Clemens; Dar... Journal: European journal of cancer Issue: Volume 140(2020) Page Start: 76 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Management, risk factors and prognostic impact of checkpoint-inhibitor pneumonitis (CIP) in lung cancer – A multicenter observational analysis. (May 2023) Authors: Frost, Nikolaj; Unger, Kristina; Blum, Torsten Gerriet; Misch, Daniel; Kurz, Sylke; Lüders, Heike; Olive, Elisabeth; Raspe, Matthias; Hilbrandt, Moritz; Koch, Myriam; Böhmer, Dirk; Senger, Carolin; Witzenrath, Martin; Grohé, Christian; Bauer, Torsten; Modest, Dominik P.; Kollmeier, Jens Journal: Lung cancer Issue: Volume 179(2023) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Mobocertinib in previously treated patients with EGFR exon 20 insertion (ex20ins) + metastatic NSCLC (mNSCLC): updated results from a phase 1/2 study. (April 2023) Authors: Popat, Sanjay; Ramalingam, Suresh; Zhou, Caicun; Kim, Tae; Yang, James; Riely, Gregory; Mekhail, Tarek; Nguyen, Danny; Garcia Campelo, Maria Rosario; Felip, Enriqueta; Misch, Daniel; Kaur, Manmit; Bunn, Veronica; Lin, Huamao; Zhang, Pingkuan; Jänne, Pasi Journal: Lung cancer Issue: Volume 178(2023)Supplement 1 Page Start: S35 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. The frequency of EGFR and KRAS mutations in non-small cell lung cancer (NSCLC): routine screening data for central Europe from a cohort study. Issue 4 (3rd April 2013) Authors: Boch, Christian; Kollmeier, Jens; Roth, Andreas; Stephan-Falkenau, Susann; Misch, Daniel; Grüning, Wolfram; Bauer, Torsten Thomas; Mairinger, Thomas Journal: BMJ open Issue: Volume 3:Issue 4(2013) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. The impact of TP53 co-mutations and immunologic microenvironment on outcome of lung cancer with EGFR exon 20 insertions. (July 2022) Authors: Christopoulos, Petros; Kluck, Klaus; Kirchner, Martina; Lüders, Heike; Roeper, Julia; Falkenstern-Ge, Roger-Fei; Szewczyk, Marlen; Sticht, Florian; Saalfeld, Felix C.; Wesseler, Claas; Hackanson, Björn; Dintner, Sebastian; Faehling, Martin; Kuon, Jonas; Janning, Melanie; Kauffmann-Guerrero, Diego... Journal: European journal of cancer Issue: Volume 170(2022) Page Start: 106 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗